Metagame

Pharma deal flow collapsed 62 percent while AI startups hide in plain sight

8 min · 19. touko 2026
jakson Pharma deal flow collapsed 62 percent while AI startups hide in plain sight kansikuva

Kuvaus

Pharma deal flow didn't collapse 62.5 percent last quarter — it just stopped filing as pharma. AI-native drug discovery companies like Recursion and Insitro are filing under "Other Technology" because their value lives in computational platforms, not clinical pipelines, which means healthcare funds tracking SEC codes are literally missing deals before they hit the committee. Total healthcare-adjacent deal count stayed completely flat at 74 deals, but if your allocation strategy runs on sector labels instead of manual tagging, you're benchmarking against a category that no longer describes where the actual capital is flowing.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity Metagame-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

44 jaksot